908 Devices Stock

908 Devices Change in Working Capital

The Change in Working Capital of 908 Devices (MASS) as of Aug 16, 2026 is -15.30 M USD. In the previous year, Change in Working Capital was -2.54 M USD — a change of 501.77% (lower).

Change in Working Capital

-15.30 MUSD

YoY

501.77%

Last updated:

Change in Working Capital of 908 Devices is 2026 -15.30 M USD. Change in Working Capital of 908 Devices was 2025 -2.54 M USD. It decreases by 501.77% lower compared to the previous year.
Access this data via the Eulerpool API

908 Devices Stock analysis

What does 908 Devices do? The company 908 Devices was founded in Boston in 2012 and specializes in the development and manufacturing of innovative analysis devices. The idea behind the company was to develop portable devices that would allow users to perform quick and accurate analyses on-site. 908 Devices' business model is based on the development and marketing of devices for the chemistry, pharmaceutical, and biotech industries, as well as for applications in the security and defense sectors. The company has several product lines tailored to different applications, including portable devices for mobile use. One of the most important branches of 908 Devices is mass spectrometry, a method used in many areas of analytics, such as forensics, environmental analysis, and food control. 908 Devices has developed a technology that allows for compact and portable mass spectrometry, which was not previously possible. Another important area of 908 Devices is chromatography, a method used for separating substances. Here too, the company has developed a technology that allows for the offering of chromatography in portable devices. 908 Devices also offers devices for molecular spectroscopy, including Raman spectroscopy, which allows for the identification and characterization of molecules. Raman spectroscopy is used in many applications, such as pharmaceutical research and material analysis. Among the products offered by 908 Devices are the M908 and MX908 devices, specifically designed for use in the security and defense industry. These devices allow for the real-time detection of a variety of hazardous substances, such as explosives, drugs, or dangerous chemicals. Another product of 908 Devices is the ZipChip device, used in biotech research. The ZipChip allows for the analysis of proteins in a very short time, which is of great importance in pharmaceutical research. The company has received several awards in recent years, including the R&D 100 Award and the Innovation Award of Analytica, one of the world's most important trade fairs for analytics and laboratory technology. Overall, 908 Devices has achieved an impressive success story and aims to revolutionize the way analyses are conducted. With its innovative products and technologies, the company has found a niche in the market and has experienced strong growth. 908 Devices is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 908 Devices stock

Change in Working Capital of 908 Devices is -15.30 M USD in 2026.

Change in Working Capital of 908 Devices changed from -2.54 M USD to -15.30 M USD, representing a 501.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital 908 Devices since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's 908 Devices historically and in real time.

Access this data via the Eulerpool API

Cash Flow — 908 Devices

All Key Metrics — 908 Devices